Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$606.10M
Total Bought:
$144.12M
Total Sold:
$210.78M
Net Transaction:
-$66.67M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apellis Pharmaceuticals Inc
COM
2,806,9802,880,880+73,900$164.99M$110.51M18.23%-$54.48M
Dianthus Therapeutics, Inc.(DNTH)1,380,6671,746,667+366,000$41.42M$45.20M7.46%+$3.78M
Structure Therapeutics IncADS506,6041,140,060+633,456$21.71M$44.77M7.39%+$23.06M
Insmed Incorporated(INSM)1,140,000650,216-489,784$30.93M$43.56M7.19%+$12.64M
Dyne Therapeutics, Inc.(DYN)1,242,9451,180,798-62,147$35.29M$41.67M6.88%+$6.38M
ArriVent BioPharma, Inc.(AVBP)1,943,8361,803,304-140,532$34.72M$33.45M5.52%-$1.27M
Verona Pharma PlcADS2,369,0001,895,200-473,800$38.12M$27.40M4.52%-$10.71M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)405,000488,000+83,000$15.89M$22.08M3.64%+$6.19M
Centessa Pharmaceuticals PlcADS2,060,1002,345,075+284,975$23.28M$21.18M3.49%-$2.10M
BridgeBio Pharma, Inc.(BBIO)690,000690,0000$21.33M$17.48M2.88%-$3.86M
Ocular Therapeutix, Inc.(OCUL)2,425,0002,425,0000$22.07M$16.59M2.74%-$5.48M
Perspective Therapeutics, Inc.(CATX)01,580,249+1,580,249$0$15.76M2.60%+$15.76M
Mind Medicine Mindmed Inc2,153,0002,153,0000$20.24M$15.52M2.56%-$4.72M
Praxis Precision Medicines, Inc.(PRAX)260,000260,0000$15.87M$10.75M1.77%-$5.11M
Taysha Gene Therapies, Inc.(TSHA)3,030,0004,572,222+1,542,222$8.70M$10.24M1.69%+$1.55M
EyePoint, Inc.(EYPT)1,093,5031,093,5030$22.60M$9.51M1.57%-$13.09M
Terns Pharmaceuticals Inc625,0001,364,400+739,400$4.10M$9.29M1.53%+$5.19M
Gossamer Bio, Inc.(GOSS)9,187,8839,187,8830$10.84M$8.28M1.37%-$2.56M
Viridian Therapeutics, Inc.(VRDN)620,000620,0000$10.86M$8.07M1.33%-$2.79M
Tenaya Therapeutics, Inc.(TNYA)2,854,0002,576,200-277,800$14.93M$7.99M1.32%-$6.94M
Regulus Therapeutics Inc04,263,701+4,263,701$0$7.61M1.26%+$7.61M
Allovir Inc4,200,0009,800,000+5,600,000$3.17M$7.09M1.17%+$3.92M
Mineralys Therapeutics, Inc.(MLYS)550,000600,000+50,000$7.10M$7.02M1.16%-$80.5K
An2 Therapeutics Inc1,103,0003,220,263+2,117,263$3.58M$6.92M1.14%+$3.34M
Akero Therapeutics Inc340,000283,372-56,628$8.59M$6.65M1.10%-$1.94M
Jasper Therapeutics, Inc.(JSPR)500,811287,500-213,311$14.70M$6.53M1.08%-$8.18M
PepGen Inc.(PEPG)376,117376,1170$5.53M$6.00M0.99%+$473.9K
Ventyx Biosciences Inc1,501,1142,391,114+890,000$8.26M$5.52M0.91%-$2.73M
Cybin D/B/A Helus Pharma(HELP)18,604,65018,604,6500$7.69M$5.04M0.83%-$2.65M
Century Therapeutics, Inc.(IPSC)540,0001,333,650+793,650$2.26M$3.40M0.56%+$1.14M
Reneo Pharmaceuticals Inc2,250,0002,250,0000$3.73M$3.40M0.56%-$337.5K
Silence Therapeutics plcADS(SLN)315,000176,000-139,000$6.80M$3.34M0.55%-$3.46M
Helix Acquisition Corp IiCL A250,000250,0000$2.59M$2.56M0.42%-$32.5K
Poseida Therapeutics Inc736,000736,0000$2.35M$2.15M0.35%-$198.7K
Elevation Oncology Inc0747,000+747,000$0$2.02M0.33%+$2.02M
Mersana Therapeutics Inc1,000,000992,000-8,000$4.48M$1.99M0.33%-$2.49M
Annexon, Inc.(ANNX)2,050,000400,000-1,650,000$14.70M$1.96M0.32%-$12.74M
Fate Therapeutics, Inc.(FATE)520,800520,8000$3.82M$1.71M0.28%-$2.11M
Nkarta, Inc.(NKTX)240,000240,0000$2.59M$1.42M0.23%-$1.18M
Nuvation Bio Inc.CL A(NUVB)1,374,870431,600-943,270$5.00M$1.26M0.21%-$3.74M
Adicet Bio Inc767,799767,7990$1.80M$929.0K0.15%-$875.3K
Rapt Therapeutics Inc292,000292,0000$2.62M$890.6K0.15%-$1.73M
Aerovate Therapeutics Inc403,685465,440+61,755$11.94M$772.6K0.13%-$11.16M
Autolus Therapeutics plcADS(AUTL)176,000176,0000$1.12M$612.5K0.10%-$510.4K
Allogene Therapeutics Inc720,0000-720,000$3.22M$0—-$3.22M
Alpine Immune Sciences Inc1,241,3000-1,241,300$49.21M$0—-$49.21M
Anaptysbio Inc165,0000-165,000$3.72M$0—-$3.72M
Arrowhead Pharmaceuticals, Inc.(ARWR)250,0000-250,000$7.15M$0—-$7.15M
Atyr Pharma Inc700,0000-700,000$1.36M$0—-$1.36M
Cabaletta Bio, Inc.(CABA)52,0000-52,000$887.1K$0—-$887.1K
Cytokinetics, Incorporated(CYTK)194,0000-194,000$13.60M$0—-$13.60M
Glycomimetics Inc3,000,0000-3,000,000$9.00M$0—-$9.00M
Immunovant, Inc.(IMVT)273,2890-273,289$8.83M$0—-$8.83M
Newamsterdam Pharma Company
ORDINARY SHARES
408,0000-408,000$9.65M$0—-$9.65M
Perspective Therapeutics, Inc.(CATX)14,718,4220-14,718,422$17.51M$0—-$17.51M
Phathom Pharmaceuticals, Inc.(PHAT)455,0000-455,000$4.83M$0—-$4.83M
Sana Biotechnology, Inc.(SANA)360,8000-360,800$3.61M$0—-$3.61M
Veru Inc.(VERU)3,800,0000-3,800,000$2.66M$0—-$2.66M
Vincerx Pharma Inc1,000,0000-1,000,000$5.06M$0—-$5.06M
Page 1 of 1